Cochrane · systematic review · CD006127
Blood pressure control for diabetic retinopathy
Do, DV, Han, G, Abariga, SA, et al. · Cochrane Database of Systematic Reviews · 2023 · Cochrane Library
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
2
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 5 · 71.4%Very low 1 · 14.3%Low 1 · 14.3%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Show all 2 versionsBlood pressure intervention/intensive blood pressure intervention compared with placebo/standard blood pressure intervention for diabetic retinopathy
Population: type 1 or type 2 diabetics
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Incidence of retinopathy by 5 years Blood pressure intervention/intensive blood pressure intervention vs placebo/standard blood pressure intervention | no estimate extracted | 1 participants | Ungraded |
Progression of retinopathy by 5 years Blood pressure intervention/intensive blood pressure intervention vs placebo/standard blood pressure intervention | no estimate extracted | 1 participants | Ungraded |
Combined incidence and progression of diabetic retinopathy by 5 years Blood pressure intervention/intensive blood pressure intervention vs placebo/standard blood pressure intervention | no estimate extracted | 1 participants | Ungraded |
Incidence of PDR/CSME/VH by 5 years Blood pressure intervention/intensive blood pressure intervention vs placebo/standard blood pressure intervention | no estimate extracted | 1 participants | Ungraded |
Visual acuity (loss of 3 lines or more) by 5 years Blood pressure intervention/intensive blood pressure intervention vs placebo/standard blood pressure intervention | RR 1.15 [0.63, 2.08] | 2 studies · 2326 participants | Very low Downgraded: risk of bias, imprecision, inconsistency |
Adverse events—all‐cause mortality Blood pressure intervention/intensive blood pressure intervention vs placebo/standard blood pressure intervention | no estimate extracted | 1 participants | Ungraded |
Adverse events—hypotension Blood pressure intervention/intensive blood pressure intervention vs placebo/standard blood pressure intervention | RR 2.04 [1.63, 2.55] | 2 studies · 3323 participants | Low Downgraded: risk of bias, imprecision |